|
1
|
Li X, Du N, Zhang Q, Li J, Chen X, Liu X,
Hu Y, Qin W, Shen N, Xu C, et al: MicroRNA-30d regulates
cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic
cardiomyopathy. Cell Death Dis. 5:e14792014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu C, Jin B, Chen L, Zhuo D, Zhang Z, Gong
K and Mao Z: MiR-30d induces apoptosis and is regulated by the
Akt/FOXO pathway in renal cell carcinoma. Cell Signal.
25:1212–1221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xin Q, Li J, Dang J, Bian X, Shan S, Yuan
J, Qian Y, Liu Z, Liu G, Yuan Q, et al: miR-155 deficiency
ameliorates autoimmune inflammation of systemic lupus erythematosus
by targeting S1pr1 in Faslpr/lpr mice. J Immunol. 194:5437–5445.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mi L, Chen Y, Zheng X, Li Y, Zhang Q, Mo D
and Yang G: MicroRNA-139-5p suppresses 3T3-L1 preadipocyte
differentiation through notch and IRS1/PI3K/Akt insulin signaling
pathways. J Cell Biochem. 116:1195–1204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Krishnan K, Steptoe AL, Martin HC,
Pattabiraman DR, Nones K, Waddell N, Mariasegaram M, Simpson PT,
Lakhani SR, Vlassov A, et al: miR-139-5p is a regulator of
metastatic pathways in breast cancer. RNA. 19:1767–1780. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maoa R, Zou F, Yang L, Lin S, Li Y, Ma M,
Yin P, Liang X and Liu J: The loss of MiR-139-5p promotes
colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt
signaling. Int J Biochem Cell Biol. 69:153–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Zhang D, Wang F, Xu D, Guo Y and
Cui W: Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497)
as novel non-invasive biomarkers for detection of cervical cancer.
Sci Rep. 5:179422015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alevizos I and Illei GG: MicroRNAs in
Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun
Rev. 9:618–621. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mameli G, Arru G, Caggiu E, Niegowska M,
Leoni S, Madeddu G, Babudieri S, Sechi GP and Sechi LA: Natalizumab
therapy modulates miR-155, miR-26a and proinflammatory cytokine
expression in MS patients. PLoS One. 11:e01571532016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Xiao X, Shen Y, Chen L, Xu C, Zhao
H, Wu Y, Zhang Q, Zhong J, Tang Z, et al: MicroRNA-32 promotes
calcification in vascular smooth muscle cells: Implications as a
novel marker for coronary artery calcification. PLoS One.
12:e01741382017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li M and Zhang J: Circulating MicroRNAs:
Potential and emerging biomarkers for diagnosis of cardiovascular
and cerebrovascular diseases. Biomed Res Int.
2015:7305352015.PubMed/NCBI
|
|
12
|
Ke ZP, Xu P, Shi Y and Gao AM: MicroRNA-93
inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by
targeting PTEN. Oncotarget. 7:28796–28805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schulte C, Karakas M and Zeller T:
microRNAs in cardiovascular disease-clinical application. Clin Chem
Lab Med. 55:687–704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun P, Wang L, Lu Y, Liu Y, Li L, Yin L,
Zhang C, Zhao W, Shen B and Xu W: MicroRNA-195 targets VEGFR2 and
has a tumor suppressive role in ACHN cells via PI3K/Akt and
Raf/MEK/ERK signaling pathways. Int J Oncol. 49:1155–1163. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen JQ, Papp G, Póliska S, Szabó K, Tarr
T, Bálint BL, Szodoray P and Zeher M: MicroRNA expression profiles
identify disease-specific alterations in systemic lupus
erythematosus and primary Sjögren's syndrome. PLoS One.
12:e01745852017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jimenez SA and Piera-Velazquez S:
Potential role of human-specific genes, human-specific microRNAs
and human-specific non-coding regulatory RNAs in the pathogenesis
of systemic sclerosis and Sjogren's syndrome. Autoimmun Rev.
12:1046–1051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Williams AE, Choi K, Chan AL, Lee YJ,
Reeves WH, Bubb MR, Stewart CM and Cha S: Sjögren's
syndrome-associated microRNAs in CD14(+) monocytes unveils targeted
TGFβ signaling. Arthritis Res Ther. 18:952016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tandon M, Gallo A, Jang SI, Illei GG and
Alevizos I: Deep sequencing of short RNAs reveals novel microRNAs
in minor salivary glands of patients with Sjögren's syndrome. Oral
Dis. 18:127–131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Li L, Jiang M and Li Y:
MicroRNA-195 inhibits human gastric cancer by directly targeting
basic fibroblast growth factor. Clin Transl Oncol. 19:1320–1328.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ustun N, Aras M, Ozgur T, Bayraktar HS,
Sefil F, Ozden R and Yagiz AE: Thymoquinone attenuates trauma
induced spinal cord damage in an animal model. Ulus Travma Acil
Cerrahi Derg. 20:328–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohta K, Hoshino H, Wang J, Ono S, Iida Y,
Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates
c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by
directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3224. 2015.
View Article : Google Scholar : PubMed/NCBI
|
